Study of ASP1948, Targeting an Immune Modulatory Receptor, in Japanese Patients With Advanced Solid Tumors
Clinical trial NCT04094506 · COMPLETED
Trial details
- NCT number
- NCT04094506
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2022-02-02
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.